N-[7,8-dichloro-1-methyl-2-oxo-6-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydroazepino[4,5-b]indol-10-yl]-2-hydroxyacetamide

C17H16Cl2F3N3O3 — CID 171774884

IUPACN-[7,8-dichloro-1-methyl-2-oxo-6-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydroazepino[4,5-b]indol-10-yl]-2-hydroxyacetamide
SMILESCC1C(=O)NCCc2c1c1c(NC(=O)CO)cc(Cl)c(Cl)c1n2CC(F)(F)F
InChIInChI=1S/C17H16Cl2F3N3O3/c1-7-12-10(2-3-23-16(7)28)25(6-17(20,21)22)15-13(12)9(24-11(27)5-26)4-8(18)14(15)19/h4,7,26H,2-3,5-6H2,1H3,(H,23,28)(H,24,27)
InChIKeyAKYKOILPJQFPRV-UHFFFAOYSA-N
MW438.23 g/mol
LogP3.22
Rot. Bonds3

About N-[7,8-dichloro-1-methyl-2-oxo-6-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydroazepino[4,5-b]indol-10-yl]-2-hydroxyacetamide

N-[7,8-dichloro-1-methyl-2-oxo-6-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydroazepino[4,5-b]indol-10-yl]-2-hydroxyacetamide (PubChem CID 171774884) has the molecular formula C17H16Cl2F3N3O3 and a molecular weight of 438.23 g/mol. Its IUPAC name is N-[7,8-dichloro-1-methyl-2-oxo-6-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydroazepino[4,5-b]indol-10-yl]-2-hydroxyacetamide.

Molecular Properties

Compound NameN-[7,8-dichloro-1-methyl-2-oxo-6-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydroazepino[4,5-b]indol-10-yl]-2-hydroxyacetamide
PubChem CID171774884
Molecular FormulaC17H16Cl2F3N3O3
Molecular Weight438.23 g/mol
Exact Mass437.05
IUPAC NameN-[7,8-dichloro-1-methyl-2-oxo-6-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydroazepino[4,5-b]indol-10-yl]-2-hydroxyacetamide
SMILESCC1C(=O)NCCc2c1c1c(NC(=O)CO)cc(Cl)c(Cl)c1n2CC(F)(F)F
InChIInChI=1S/C17H16Cl2F3N3O3/c1-7-12-10(2-3-23-16(7)28)25(6-17(20,21)22)15-13(12)9(24-11(27)5-26)4-8(18)14(15)19/h4,7,26H,2-3,5-6H2,1H3,(H,23,28)(H,24,27)
InChIKeyAKYKOILPJQFPRV-UHFFFAOYSA-N
XLogP3.22
TPSA83.36 Ų
H-Bond Donors3
H-Bond Acceptors4
Rotatable Bonds3
Heavy Atoms28
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500438.23
LogP ≤ 53.22
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 104

Analyze N-[7,8-dichloro-1-methyl-2-oxo-6-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydroazepino[4,5-b]indol-10-yl]-2-hydroxyacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[7,8-dichloro-1-methyl-2-oxo-6-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydroazepino[4,5-b]indol-10-yl]-2-hydroxyacetamide?
The IUPAC name of N-[7,8-dichloro-1-methyl-2-oxo-6-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydroazepino[4,5-b]indol-10-yl]-2-hydroxyacetamide (CID 171774884) is N-[7,8-dichloro-1-methyl-2-oxo-6-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydroazepino[4,5-b]indol-10-yl]-2-hydroxyacetamide.
What is the SMILES notation for N-[7,8-dichloro-1-methyl-2-oxo-6-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydroazepino[4,5-b]indol-10-yl]-2-hydroxyacetamide?
The canonical SMILES for N-[7,8-dichloro-1-methyl-2-oxo-6-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydroazepino[4,5-b]indol-10-yl]-2-hydroxyacetamide is CC1C(=O)NCCc2c1c1c(NC(=O)CO)cc(Cl)c(Cl)c1n2CC(F)(F)F.
What is the InChIKey of N-[7,8-dichloro-1-methyl-2-oxo-6-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydroazepino[4,5-b]indol-10-yl]-2-hydroxyacetamide?
The InChIKey is AKYKOILPJQFPRV-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H16Cl2F3N3O3/c1-7-12-10(2-3-23-16(7)28)25(6-17(20,21)22)15-13(12)9(24-11(27)5-26)4-8(18)14(15)19/h4,7,26H,2-3,5-6H2,1H3,(H,23,28)(H,24,27).
What are the key properties of N-[7,8-dichloro-1-methyl-2-oxo-6-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydroazepino[4,5-b]indol-10-yl]-2-hydroxyacetamide?
N-[7,8-dichloro-1-methyl-2-oxo-6-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydroazepino[4,5-b]indol-10-yl]-2-hydroxyacetamide has a molecular weight of 438.23 g/mol, XLogP of 3.22, 3 rotatable bonds, 3 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[7,8-dichloro-1-methyl-2-oxo-6-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydroazepino[4,5-b]indol-10-yl]-2-hydroxyacetamide is sourced from PubChem (CID 171774884), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).